Encompass Health Corporation Common Stock (EHC)

Health care services provider Encompass Health (NYSE:EHC) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 10.6% year on year to $1.46 billion. The company’s full-year revenue guidance of $5.89 billion at the midpoint came in 0.5% above analysts’ estimates. Its non-GAAP profit of $1.37 per share was 15% above analysts’ consensus estimates.

While the healthcare sector has been remarkably stable, three firms in particular stand out for a closer look as the second half of 2025 approaches.

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Healthcare services company The Ensign Group (NASDAQ:ENSG). will be reporting earnings tomorrow after market close. Here’s what investors should know.

The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.

Health care services provider Encompass Health (NYSE:EHC) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 10.6% year on year to $1.46 billion. The company’s full-year revenue guidance of $5.89 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $1.37 per share was 14.9% above analysts’ consensus estimates.

Health care services provider Encompass Health (NYSE:EHC) will be reporting results tomorrow after market close. Here’s what you need to know.

A number of stocks fell in the afternoon session after President Trump criticized the Federal Reserve's approach to interest rate cuts, warning that the pace was slow and could hinder economic growth. Trump's comments added pressure to an already sensitive market, raising concerns about political interference in monetary policy. 

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Encompass Health (NYSE:EHC) and its peers.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at outpatient & specialty care stocks, starting with Select Medical (NYSE:SEM).

Encompass Health currently trades at $100.30 per share and has shown little upside over the past six months, posting a middling return of 3.8%. However, the stock is beating the S&P 500’s 1.4% decline during that period.